{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:10:20Z","timestamp":1756285820977,"version":"3.44.0"},"reference-count":36,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1136\/dtb.2021.234508rep","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T21:56:52Z","timestamp":1612907812000},"page":"139-143","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Republished: Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiency"],"prefix":"10.1136","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4627-1386","authenticated-orcid":false,"given":"Natasha","family":"Daga","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Central Coast Local Health District, Gosford, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavian","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Central Coast Local Health District, Gosford, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"2025082701345035000_59.9.139.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044459"},{"key":"2025082701345035000_59.9.139.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2814"},{"key":"2025082701345035000_59.9.139.3","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070809"},{"key":"2025082701345035000_59.9.139.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2008.04.007"},{"key":"2025082701345035000_59.9.139.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809493"},{"key":"2025082701345035000_59.9.139.6","unstructured":"Amgen Australia Pty Ltd . Australian product information \u2013 PROLIA (denosumab) solution for injection, 2019. Available: http:\/\/www.guildlink.com.au\/gc\/ws\/amgen\/pi.cfm?product=anpprolm10315"},{"key":"2025082701345035000_59.9.139.7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0014"},{"key":"2025082701345035000_59.9.139.8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cen.12188","article-title":"Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis","volume":"79","author":"Makras","year":"2013","journal-title":"Clin Endocrinol"},{"key":"2025082701345035000_59.9.139.9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"2025082701345035000_59.9.139.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.05.016"},{"key":"2025082701345035000_59.9.139.11","first-page":"63","article-title":"Denosumab-Induced severe hypocalcaemia in chronic kidney disease","volume":"2018","author":"Jalleh","year":"2018","journal-title":"Case Rep Nephrol Urol"},{"key":"2025082701345035000_59.9.139.12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000499824","article-title":"Symptomatic hypocalcemia due to denosumab administration: treatment and clinical course","volume":"9","author":"Strickling","year":"2019","journal-title":"Case Rep Nephrol Dial"},{"key":"2025082701345035000_59.9.139.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-011-0950-5"},{"key":"2025082701345035000_59.9.139.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2007.11.003"},{"key":"2025082701345035000_59.9.139.15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.642"},{"key":"2025082701345035000_59.9.139.16","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2014.273979"},{"key":"2025082701345035000_59.9.139.17","unstructured":"Electronic Therapeutic Guidelines [eTG] . Hypophosphataemia, 2019. Available: https:\/\/tgldcdp.tg.org.au.acs.hcn.com.au\/viewTopic?topicfile=hypophosphataemia [Accessed Jan 2020]."},{"key":"2025082701345035000_59.9.139.18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1319"},{"key":"2025082701345035000_59.9.139.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.02.007"},{"key":"2025082701345035000_59.9.139.20","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v1.i6.151"},{"key":"2025082701345035000_59.9.139.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-011-0275-7"},{"key":"2025082701345035000_59.9.139.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132119","article-title":"Low 25-hydroxyvitamin D levels are associated with infections and mortality in patients with cirrhosis","volume":"10","author":"Finkelmeier","year":"2015","journal-title":"PLoS One"},{"key":"2025082701345035000_59.9.139.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2008.01.007"},{"key":"2025082701345035000_59.9.139.24","unstructured":"Osteoporosis Australia . Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age. RACGP (the Royal Australian College of general practitioners), 2017. Available: https:\/\/www.racgp.org.au\/clinical-resources\/clinical-guidelines\/key-racgp-guidelines\/view-all-racgp-guidelines\/osteoporosis [Accessed Jan 2020]."},{"key":"2025082701345035000_59.9.139.25","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1210\/jc.2013-4175","article-title":"Clinical trials express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (direct)","volume":"99","author":"Nakamura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082701345035000_59.9.139.26","doi-asserted-by":"publisher","DOI":"10.1159\/000380960"},{"key":"2025082701345035000_59.9.139.27","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12283."},{"key":"2025082701345035000_59.9.139.28","unstructured":"Center for Drug Evaluation and Research . Review of Denosumab\u2019s Post-Marketing Study Information from Amgen's Complete Response. Food and Drug Administration, 2010. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/125320s000MedR.pdf [Accessed Jan 2020]."},{"key":"2025082701345035000_59.9.139.29","doi-asserted-by":"publisher","DOI":"10.1530\/EC-16-0056"},{"key":"2025082701345035000_59.9.139.30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0889-8529(18)30171-3","article-title":"Hypocalcemic emergencies","volume":"22","author":"Tohme","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2025082701345035000_59.9.139.31","unstructured":"Phebra Pty Ltd . Australian product Information- calcium gluconate injection, 2020. Available: https:\/\/www.phebra.com\/wp-content\/uploads\/2018\/10\/Calcium-gluconate_PI_v11.pdf [Accessed Jan 2020]."},{"key":"2025082701345035000_59.9.139.32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2044.1998.00463.x"},{"key":"2025082701345035000_59.9.139.33","first-page":"175","article-title":"A rapid intravenous phosphate replacement protocol for critically ill patients","volume":"6","author":"French","year":"2004","journal-title":"Crit Care Resusc"},{"key":"2025082701345035000_59.9.139.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-1872-2"},{"key":"2025082701345035000_59.9.139.35","unstructured":"Food and Drug Administration . NDA\/BLA multidisciplinary review and evaluation NDA 212832 potassium phosphates injection, USP, 2019. Available: https:\/\/www.fda.gov\/media\/133481\/download [Accessed Mar 2020]."},{"key":"2025082701345035000_59.9.139.36","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012030223"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2021.234508rep","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:35:02Z","timestamp":1756283702000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2021.234508rep"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,8,24]]},"published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1136\/dtb.2021.234508rep"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2021.234508rep","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2021,2,9]]}}}